Quantcast
Last updated on April 18, 2014 at 13:23 EDT

Latest Charles Perou Stories

Biological Diversity In Triple-negative Breast Cancer Discovered By Researchers
2013-02-14 12:25:02

University of North Carolina Health Care Triple-negative breast cancers are more biologically diverse than previously believed and classification should be expanded to reflect this heterogeneity, according to University of North Carolina researchers. In a study published in the February issue of The Oncologist conducted by UNC and the Vall d'Hebron Institute of Oncology in Barcelona, Spain, a team lead by Charles Perou, PhD, of UNC Lineberger Comprehensive Cancer Center, examined more...

2012-09-24 13:59:47

A team of scientists with The Cancer Genome Atlas program reports their genetic characterization of 800 breast tumors, including finding some of the genetic causes of the most common forms of breast cancer, providing clues for new therapeutic targets, and identifying a molecular similarity between one sub-type of breast cancer and ovarian cancer. Their findings, which offer a more comprehensive understanding of the mechanisms behind each sub-type of breast cancer, are reported in the...

2012-08-30 06:25:16

DURHAM, N.C., Aug. 30, 2012 /PRNewswire/ -- GeneCentric announced today that it has been launched with two separate exclusive licenses to diagnostic technologies from the University of North Carolina at Chapel Hill. The company was co-founded in 2011 by two pioneers in cancer research, Drs. Charles Perou and Neil Hayes, who discovered molecular signatures critical in distinguishing clinically relevant subtypes of lung cancer. GeneCentric in-licensed the Lung Subtype Platform (LSP(TM))...